Breaking News Instant updates and real-time market news.

PANW

Palo Alto Networks

$176.04

-0.46 (-0.26%)

04:55
11/30/18
11/30
04:55
11/30/18
04:55

Palo Alto Networks upgraded to Strong Buy from Outperform at First Analysis

First Analysis analyst Howard Smith upgraded Palo Alto Networks to Strong Buy with an unchanged price target of $240. The "strong" fiscal Q1 results and above-consensus fiscal 2019 outlook reinforce the view that "solid global execution and the expansion of its resonating enterprise security platform should reward shareholders," Smith tells investors in a research note. Further, he believes the recent slide in the shares has created a more compelling entry point.

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 13

    Dec

  • 19

    Dec

  • 09

    Jan

  • 10

    Jan

PANW Palo Alto Networks
$176.04

-0.46 (-0.26%)

11/27/18
JMPS
11/27/18
NO CHANGE
Target $270
JMPS
Outperform
Palo Alto Networks checks support above consensus view, says JMP Securities
JMP Securities analyst Erik Suppiger said feedback from his channel checks, and the results of the other firewall vendors this quarter, lead him to continue to believe Palo Alto Networks' core firewall business remains robust and that the company will report Q1 results that top consensus estimates. He also expects the company to guide in-line to slightly higher than the Q2 consensus, added Suppiger, who keeps an Outperform rating and $270 price target on Palo Alto shares.
11/19/18
UBSW
11/19/18
NO CHANGE
Target $232
UBSW
Neutral
Palo Alto Networks lack of visibility one reason for weakness, says UBS
UBS analyst Fatima Boolani noted Palo Alto Networks' shares are down roughly 30% from its mid-September highs and she sees several reasons. The pace of leadership transitions has stoked concerns of execution risks and strategy shift, combined with limited visibility into the growth/investment framework, along with lingering concerns of large and/or dilutive M&A, has pushed its valuation down to five-year troughs, said Boolani. She maintained her Neutral rating and $232 price target on Palo Alto shares.
11/15/18
JMPS
11/15/18
NO CHANGE
JMPS
Market Perform
Cisco results bode well for Arista Networks, Nutanix, says JMP Securities
JMP Securities analyst Erik Suppiger noted that Cisco (CSCO) reported Q1 EPS and revenues ahead of consensus, stating that he believes the "robust" results bode well for the broader networing and security markets, including vendors such as Arista Networks (ANET), Nutanix (NTNX), Extreme Networks (EXTR) and Palo Alto Networks (PANW). Service provider bookings had positive growth for the second consecutive quarter, though management acknowledged that the growth may not be sustainable and Suppiger said he thinks this quarter included a large deal with T-Mobile (TMUS). The strength in data center and campus switching that Cisco called out suggests market demand trends are favorable for Arista and Extreme Networks, said the analyst. The strength in Cisco's hyperconverged infrastructure product, HyperFlex, suggests demand is favorable for Nutanix, he added. Suppiger, who views Cisco shares as fairly valued, keeps a Market Perform rating on the stock.
11/15/18
STFL
11/15/18
NO CHANGE
Target $240
STFL
Buy
Palo Alto Networks investors should temper upside expectations, says Stifel
Stifel analyst Gur Talpaz said that after conducting multiple channel checks with key Palo Alto partners following the conclusion of the company's fiscal first quarter he believes shipment activity reverted back to a more normalized pattern this quarter. Given a return to more normalized supply chain activity, along with incrementally more discounting due to product maturity, he thinks investors should "temper their expectations" about the magnitude of potential Q1 upside. Talpaz lowered his price target on Palo Alto shares to $240 from $260, but maintains a Buy rating on the stock.

TODAY'S FREE FLY STORIES

MLNT

Melinta Therapeutics

$1.71

0.15 (9.62%)

13:48
12/12/19
12/12
13:48
12/12/19
13:48
Hot Stocks
FDA approves Melinta Therapeutics sNDA for Orbactiv for injection »

A letter posted by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$122.30

-0.08 (-0.07%)

13:45
12/12/19
12/12
13:45
12/12/19
13:45
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

KW

Kennedy Wilson

$22.26

-0.25 (-1.11%)

13:44
12/12/19
12/12
13:44
12/12/19
13:44
Hot Stocks
Kennedy Wilson raises quarterly dividend 5% to 22c per share »

Kennedy Wilson announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

, SPX

S&P 500

$0.00

(0.00%)

13:38
12/12/19
12/12
13:38
12/12/19
13:38
Periodicals
WH Press Secretary says President to hold trade meeting at 2:30, CNBC reports »

CNBC political reporter…

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$67.62

0.48 (0.71%)

13:36
12/12/19
12/12
13:36
12/12/19
13:36
Periodicals
PrEP4All says USPTO adviser showed 'bias' in favor of Gilead, STAT reports »

An AIDS activist group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$8.98

0.01 (0.11%)

13:35
12/12/19
12/12
13:35
12/12/19
13:35
Options
Barclays put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.37

0.385 (3.51%)

13:20
12/12/19
12/12
13:20
12/12/19
13:20
Options
Largest trade of the day is a Jan 2021 GE 1x3 totalling 108K contracts »

Largest trade of the day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

13:20
12/12/19
12/12
13:20
12/12/19
13:20
General news
Treasury's $16 B 30-year bond reopening was very, very well received »

Treasury's $16 B…

HIIQ

Health Insurance Innovations

$19.23

0.88 (4.80%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/12/19
12/12
13:16
12/12/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

INSG

Inseego

$7.67

0.24 (3.23%)

13:05
12/12/19
12/12
13:05
12/12/19
13:05
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.16

1.675 (48.06%)

13:00
12/12/19
12/12
13:00
12/12/19
13:00
Recommendations
Amneal Pharmaceuticals analyst commentary  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$219.47

-0.59 (-0.27%)

, PTI

Proteostasis

$4.01

-0.23 (-5.42%)

12:55
12/12/19
12/12
12:55
12/12/19
12:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

VRTX

Vertex

$219.47

-0.59 (-0.27%)

PTI

Proteostasis

$4.01

-0.23 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Mar

ADBE

Adobe

$304.30

0.55 (0.18%)

, AVGO

Broadcom

$324.00

4.14 (1.29%)

12:53
12/12/19
12/12
12:53
12/12/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$304.30

0.55 (0.18%)

AVGO

Broadcom

$324.00

4.14 (1.29%)

COST

Costco

$295.82

0.6 (0.20%)

ORCL

Oracle

$56.16

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 23

    Jan

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
U.S. Household net worth rose »

U.S. Household net worth…

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
Treasury Action: yields remain near their highs of the sessio »

Treasury Action: yields…

CC

Chemours

$17.55

0.955 (5.75%)

12:45
12/12/19
12/12
12:45
12/12/19
12:45
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:41
12/12/19
12/12
12:41
12/12/19
12:41
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

12:36
12/12/19
12/12
12:36
12/12/19
12:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

PBYI

Puma Biotechnology

$8.89

0.18 (2.07%)

12:32
12/12/19
12/12
12:32
12/12/19
12:32
Hot Stocks
Puma Biotechnology: plasmaMATCH trial shows neratinib activity in ERBB2 cancer »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

, GOOG

Alphabet

$1,346.41

1.27 (0.09%)

12:31
12/12/19
12/12
12:31
12/12/19
12:31
Hot Stocks
Google updates Messages with Verified SMS, spam protection »

Google announced in a…

GOOGL

Alphabet Class A

$1,344.42

-0.23 (-0.02%)

GOOG

Alphabet

$1,346.41

1.27 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$41.93

1.7 (4.23%)

12:29
12/12/19
12/12
12:29
12/12/19
12:29
Conference/Events
GrubHub participates in a conference call with Benchmark »

Services/Media Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.